Spectral Medical Inc.
Pagina dedicata companiei Spectral Medical Inc. listata cu simbolul CA.EDT
Descriere companie[edit | ]
Spectral Medical Inc. (http://www.spectraldx.com/) is a late stage theranostic company that is focused on advancing therapeutic options for sepsis and septic shock. The Company has conducted a Phase III clinical trial for its lead product, PMX (Toraymyxin PMX-20R), which is for the treatment of patients with septic shock and endotoxemia that is measured by the Company’s Endotoxin Activity Assay (EAA). EAA and PMX are both Health Canada licensed and commercially available in Canada. The Company through its wholly owned subsidiary, Dialco Medical Inc., is also commercializing a new set of platforms addressing renal replacement therapy (RRT) across the dialysis spectrum. SAMI is targeting the acute RRT market, while DIMI is targeting the chronic RRT market.
Grafic actiuni companie[edit | ]